In 2008, two of the three types of human recurrent ovarian tumors displaying mutations restoring an open reading frame (ORF) function and loss of the mutant BRCA2 allele were reported, and the outcomes were a corrected frameshift of BRCA reading frame [113]. The gene discussed is BRCA2; the disease is ovarian neoplasm.